Clinical Trials Directory

Trials / Sponsors / Presidio Pharmaceuticals, Inc.

Presidio Pharmaceuticals, Inc.

Industry · 7 registered clinical trials.

StatusTrialPhaseStarted
CompletedPhase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations
Pharmacokinetic Assessments in Healthy Volunteers
Phase 12014-10-01
CompletedPhase 1 Study of Relative Bioavailability of PPI-668 Tablet and Capsule Formulations
Pharmacokinetic Assessments in Healthy Volunteers
Phase 12013-10-01
CompletedA Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients
Hepatitis C, Chronic
Phase 12013-08-01
CompletedStudy of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis
Chronic Hepatitis C
Phase 22013-05-01
CompletedA Drug Interaction Study of the Effects of PPI-668 on the Pharmacokinetics of Midazolam and Omeprazole
Pharmacokinetic Assessments in Healthy Volunteers
Phase 12013-02-01
CompletedA Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1
Hepatitis C, Chronic
Phase 12011-10-01
CompletedA Phase 1b Study of PPI-461 in Patients With HCV Genotype 1
Chronic Genotype 1 Hepatitis C Virus Infection
Phase 12010-10-01